Geraldine Ferron-Brady

9PUBLICATIONS
23CO-AUTHORS
PharmacogenomicsPharmaceutical delivery technologiesChemotherapyGene and molecular therapyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 30, 2026
Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma.

|Jun 04, 2026
Simulation Framework to Investigate Efficacy and Ocular Safety of Belantamab Mafodotin Combinations in Relapsed/Refractory Multiple Myeloma.

|Apr 13, 2026
Exposure-response analyses for belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma from DREAMM-6 Arm B and DREAMM-7.

Theodoros Papathanasiou, Xi Chen, Fernando Carreno

|Oct 07, 2025
Population Pharmacokinetics and Exposure-Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis.

Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho

|Aug 27, 2024
Momelotinib: Mechanism of action, clinical, and translational science.

Georgios Vlasakakis, Michael T McCabe, Yu Liu Ho

|Apr 18, 2024
Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters.

Yu Liu Ho, Pete Gorycki, Geraldine Ferron-Brady

Pageof 2

Frequent Collaborators

4 joint publications

Yu Liu Ho

3 joint publications

Sandra A G Visser

3 joint publications

Georgios Vlasakakis

2 joint publications

Teun M Post